Gerresheimer ends talks with private equity investors

Gerresheimer ends talks with private equity investors

German packaging and medical equipment maker Gerresheimer has terminated discussions regarding a potential sale of the company, according to a statement released on July 16, 2025 [1]. The company had previously disclosed in February that it was engaged in early discussions with private equity investors about a possible sale.

After a thorough analysis, Gerresheimer believes that continuing the discussions is not in the best interest of the company and its stakeholders [2]. The company will now focus on its strategic direction and the implementation of global growth projects, particularly in the area of systems and solutions for biologics.

Gerresheimer will provide a strategy update at a Capital Market Day on October 15, 2025, which will include the results of the strategic review of the Moulded Glass business and a new segmentation to improve transparency towards the capital market [3]. The company expects organic revenue growth of 6-9% and an organic adjusted EBITDA margin of 23-25% in the mid-term [4].

The acquisition of Bormioli Pharma has added further primary packaging made of glass and plastic as well as closure solutions, accessories, and dosing systems to Gerresheimer's product portfolio, creating new opportunities for system integration for high-value plastic solutions [3]. This strategic review is to be accelerated in the coming months.

References:
[1] https://www.investing.com/news/stock-market-news/gerresheimer-ends-talks-on-potential-company-sale-93CH-4138269
[2] https://www.bizjournals.com/philadelphia/news/2025/07/14/pci-pharma-bain-capital-philadelphia.html
[3] https://www.finanzen.at/nachrichten/aktien/eqs-news-gerresheimer-ends-discussions-with-private-equity-investors-about-a-potential-takeover-offer-1034904888
[4] https://www.webdisclosure.com/press-release/gerresheimer-ends-discussions-with-private-equity-investors-about-a-potential-takeover-offer-lMsjf2ulPFX